Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1465-993X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer ; volume:24 ; number:1 ; day:25 ; month:1 ; year:2023 ; pages:1-10 ; date:12.2023
Respiratory research ; 24, Heft 1 (25.1.2023), 1-10, 12.2023

Creator: Yao, Yu
Yang, Huaping
Zhu, Bo
Wang, Song
Pang, Jiaohui
Wu, Xiaoying
Xu, Yang
Zhang, Junli
Zhang, Jinfeng
Ou, Qiuxiang
Tian, Hui
Zhao, Zheng

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12931-023-02329-1

URN: urn:nbn:de:101:1-2023040309403057204695

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:58 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Yao, Yu
Yang, Huaping
Zhu, Bo
Wang, Song
Pang, Jiaohui
Wu, Xiaoying
Xu, Yang
Zhang, Junli
Zhang, Jinfeng
Ou, Qiuxiang
Tian, Hui
Zhao, Zheng
SpringerLink (Online service)

Other Objects (12)

RET fusions as primary oncogenic drivers and secondary acquired resistance to EGFR tyrosine kinase inhibitors in patients with non-small-cell lung cancer

Editorial: Targeting bruton tyrosine kinase

Subsequent chemotherapy reverses acquired tyrosine kinase inhibitor resistance and restores response to tyrosine kinase inhibitor in advanced non-small-cell lung cancer

Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML

Newer Tyrosine Kinase Inhibitors for CML

Second-generation inhibitors of Bruton tyrosine kinase

Targeting tumour microenvironment by tyrosine kinase inhibitor

Bcr-Abl tyrosine kinase inhibitors- current status

Auto-thiophosphorylation activity of Src tyrosine kinase

VEGFR1-tyrosine kinase signaling in pulmonary fibrosis

Pay structure and firm technological innovation: comparative research based on three pay gaps

$On the periodic boundary value problems for fractional nonautonomous differential equations with non-instantaneous impulses$

On the periodic boundary value problems for fractional nonautonomous differential equations with non-instantaneous impulses

RET fusions as primary oncogenic drivers and secondary acquired resistance to EGFR tyrosine kinase inhibitors in patients with non-small-cell lung cancer

Editorial: Targeting bruton tyrosine kinase

Subsequent chemotherapy reverses acquired tyrosine kinase inhibitor resistance and restores response to tyrosine kinase inhibitor in advanced non-small-cell lung cancer

Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML

Newer Tyrosine Kinase Inhibitors for CML

Second-generation inhibitors of Bruton tyrosine kinase

Targeting tumour microenvironment by tyrosine kinase inhibitor

Bcr-Abl tyrosine kinase inhibitors- current status

Auto-thiophosphorylation activity of Src tyrosine kinase

VEGFR1-tyrosine kinase signaling in pulmonary fibrosis

Pay structure and firm technological innovation: comparative research based on three pay gaps

$On the periodic boundary value problems for fractional nonautonomous differential equations with non-instantaneous impulses$

On the periodic boundary value problems for fractional nonautonomous differential equations with non-instantaneous impulses

RET fusions as primary oncogenic drivers and secondary acquired resistance to EGFR tyrosine kinase inhibitors in patients with non-small-cell lung cancer

Editorial: Targeting bruton tyrosine kinase

Subsequent chemotherapy reverses acquired tyrosine kinase inhibitor resistance and restores response to tyrosine kinase inhibitor in advanced non-small-cell lung cancer

Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML

Newer Tyrosine Kinase Inhibitors for CML

Second-generation inhibitors of Bruton tyrosine kinase

Targeting tumour microenvironment by tyrosine kinase inhibitor

Bcr-Abl tyrosine kinase inhibitors- current status

Auto-thiophosphorylation activity of Src tyrosine kinase

VEGFR1-tyrosine kinase signaling in pulmonary fibrosis

Pay structure and firm technological innovation: comparative research based on three pay gaps

$On the periodic boundary value problems for fractional nonautonomous differential equations with non-instantaneous impulses$

On the periodic boundary value problems for fractional nonautonomous differential equations with non-instantaneous impulses

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

RET fusions as primary oncogenic drivers and secondary acquired resistance to EGFR tyrosine kinase inhibitors in patients with non-small-cell lung cancer

Editorial: Targeting bruton tyrosine kinase

Subsequent chemotherapy reverses acquired tyrosine kinase inhibitor resistance and restores response to tyrosine kinase inhibitor in advanced non-small-cell lung cancer

Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML

Newer Tyrosine Kinase Inhibitors for CML

Second-generation inhibitors of Bruton tyrosine kinase

Targeting tumour microenvironment by tyrosine kinase inhibitor

Bcr-Abl tyrosine kinase inhibitors- current status

Auto-thiophosphorylation activity of Src tyrosine kinase

VEGFR1-tyrosine kinase signaling in pulmonary fibrosis

Pay structure and firm technological innovation: comparative research based on three pay gaps

On the periodic boundary value problems for fractional nonautonomous differential equations with non-instantaneous impulses

RET fusions as primary oncogenic drivers and secondary acquired resistance to EGFR tyrosine kinase inhibitors in patients with non-small-cell lung cancer

Editorial: Targeting bruton tyrosine kinase

Subsequent chemotherapy reverses acquired tyrosine kinase inhibitor resistance and restores response to tyrosine kinase inhibitor in advanced non-small-cell lung cancer

Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML

Newer Tyrosine Kinase Inhibitors for CML

Second-generation inhibitors of Bruton tyrosine kinase

Targeting tumour microenvironment by tyrosine kinase inhibitor

Bcr-Abl tyrosine kinase inhibitors- current status

Auto-thiophosphorylation activity of Src tyrosine kinase

VEGFR1-tyrosine kinase signaling in pulmonary fibrosis

Pay structure and firm technological innovation: comparative research based on three pay gaps

On the periodic boundary value problems for fractional nonautonomous differential equations with non-instantaneous impulses

RET fusions as primary oncogenic drivers and secondary acquired resistance to EGFR tyrosine kinase inhibitors in patients with non-small-cell lung cancer

Editorial: Targeting bruton tyrosine kinase

Subsequent chemotherapy reverses acquired tyrosine kinase inhibitor resistance and restores response to tyrosine kinase inhibitor in advanced non-small-cell lung cancer

Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML

Newer Tyrosine Kinase Inhibitors for CML

Second-generation inhibitors of Bruton tyrosine kinase

Targeting tumour microenvironment by tyrosine kinase inhibitor

Bcr-Abl tyrosine kinase inhibitors- current status

Auto-thiophosphorylation activity of Src tyrosine kinase

VEGFR1-tyrosine kinase signaling in pulmonary fibrosis

Pay structure and firm technological innovation: comparative research based on three pay gaps

On the periodic boundary value problems for fractional nonautonomous differential equations with non-instantaneous impulses

Related objects

Reset password